Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Guardant Health, Inc. (NASDAQ: GH)
GH Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
17.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
0.20%
GH Stock Analysis
GH
PE Ratio:
GH
PEG Ratio:
Not Available
GH
Forward EPS Growth (12 month):
0.00%
GH
PS Ratio:
15.6
GH
PSG Ratio:
0.6
GH
Forward Revenue Growth (12 month):
28.20%
GH Articles
No data was found